Wealth is personal

Our solutions are as unique as our clients themselves.

Integral philosophy

Reichmuth & Co’s integral philosophy helps us to get to know our customers and their needs and develop tailor-made solutions.

Asset management and advice

We offer our clients and their families tailor-made private banking solutions. Always with the aim of protecting, growing and aligning their assets.

Investment solutions

Our experienced investment experts are constantly developing a wide range of innovative and strongly performing investment solutions for you. From traditional investments to infrastructure investments.

«We listen to you carefully so we can understand your goals and work out a solution that adds value and takes the pressure off you.»

Jürg Staub

partner with unlimited liability

Forward-looking investment approach

Markets are not efficient and people are not rational either. That is why we think in terms of scenarios, which we use to develop a forward-looking investment strategy.

Get to know us personally.

News

Liability instead of rescue – an appeal from private bankers to politicians

As part of a broad-based initiative to strengthen personal responsibility in the banking sector, a guest article entitled “Haften statt retten” (Liability instead of rescue) was published in the Neue Zürcher Zeitung (NZZ) on September 1, 2025. The article was written by Christian Bidermann, partner at Rahn & Bodmer and Jürg Staub, general partner at Reichmuth & Co.

Read more

Is the Swiss currency rocket taking off?

Switzerland is sitting on a ticking currency time bomb: the Swiss franc. What has been regarded as a sign of stability and solidity for years could prove highly explosive in the event of a new global economic shock. While the Swiss Confederation shines as a safe haven with one of the lowest debt ratios in the world and a credible monetary stability policy pursued by the SNB, it is precisely this status that threatens to become a challenge.

Read more

Swiss pharmaceutical industry facing political headwinds

The pharmaceutical industry is currently high on Donald Trump’s list of priorities. He wants more production and jobs in the US, as well as lower drug prices. As a means of exerting pressure, he is threatening to impose price caps and introduce tariffs on drugs. These goals are, of course, contradictory, which is causing even more uncertainty.

Read more